Xcout Intel
MinervaX competitors & alternatives
The 12 closest competitors and alternatives to MinervaX among drug discovery companies — ranked by similarity to what MinervaX actually does, not by market-cap band.
Subscribe to see MinervaX’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About MinervaX
MinervaX is a privately held biotechnology company headquartered in Copenhagen, Denmark, pursuing the development of a novel maternal prophylactic vaccine for the prevention of Group B Streptococcus disease.
MinervaX at a glance
MinervaX is a drug discovery company headquartered in Denmark. Xcout tracks 10 named people at MinervaX, including Veronica Gambillara Fonck (Chair of the Board).
MinervaX leadership
- Veronica Gambillara FonckChair of the Board
- Bita SehatBoard member
- Christopher GagliardiBoard member
- Emmanuelle CoutanceauBoard member
- Kabeer AzizBoard member
- Patrik SobockiBoard member
4 more named people on record for MinervaX, with roles, board committees and tenure — see the full roster →
Top 12 MinervaX competitors
Ranked by semantic similarity — how close each company is to MinervaX by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Smartbax is a biotechnology startup founded in Munich, Germany, in 2021, dedicated to developing innovative next-generation antibiotics to combat the rising threat of multidrug-resistant bacteria.
Similar drug discovery company
ApoGlyx is a Swedish life science company located in Lund that focuses on developing innovative medicines for acute systemic inflammatory diseases such as sepsis and acute pancreatitis.
Similar drug discovery company
ReproNovo is a biopharmaceutical company dedicated to developing innovative treatments for reproductive medicine. Headquartered in Lausanne, Switzerland, the company maintains primary development operations in Copenhagen, Denmark, and an additional site in Barcelona, Spain. It is backed by prominent life sciences investors.
Similar drug discovery company
Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.
Similar drug discovery company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Similar drug discovery company
Tacalyx is a life sciences and biotechnology company headquartered in Berlin, Germany, focused on developing lead TACA-targeted therapeutics.
Similar drug discovery company
Astria Therapeutics, Inc. is a public biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to developing life-changing therapies for patients.
Similar drug discovery company
Omniox, Inc. is an early-stage biopharmaceutical company located in San Francisco, California, focused on developing new medicines for hypoxic diseases.
Similar drug discovery company
Kinoxis Therapeutics Pty Ltd is an Australian-based, clinical-stage biotechnology company that develops first-in-class therapeutics targeting ALOX15 to address central nervous system (CNS) diseases.
Biopharmaceuticals
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
Biopharmaceuticals
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
Biopharmaceuticals
Allievex Corporation was a clinical-stage biotechnology company that developed novel therapies for rare pediatric neurodegenerative diseases, including an enzyme replacement therapy licensed from BioMarin for Sanfilippo type B. Founded by Pappas Capital, the company terminated its business operations and clinical studies in October 2023.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of MinervaX and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for MinervaXand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →